Difficulties Imaging Herpes Simplex Keratitis With Fluorescein Isothiocynate-Labeled Anti-HSV-1 Antibodies in an Ex Vivo Model

Elena S. Novitskaya, Victoria McGilligan, Johnny Moore, Anant Sharma, Simon J. Dean, Tara Moore

Research output: Contribution to journalArticle

Abstract

Aim: The aim of this study was to attempt to visualize herpes simplex keratitis in an ex vivo model using currently available ophthalmological equipment and anti-herpes simplex virus I (HSV-1) fluorescein isothiocynate-labeled antibody. Methods: Sixteen donor human corneas were included in this study. Eight corneas were infected with HSV-1, whereas 8 remained uninfected. Abrasions were made on 2 infected and 2 uninfected corneas to assess a possible nonspecific absorption of antibodies in the sites of corneal epithelial defects. Corneas were examined before and after antibody application using a slit lamp, the fluorescein enhancing filter settings of fundus camera, and Confoscan 3. All corneas were further imaged using multiphoton laser confocal microscopy. Results: Before anti-HSV-1 antibody application, no fluorescence was detected in donor corneas with the blue light of the slit lamp and fundus camera at fluorescein enhancing filter settings. Examination with the fundus camera after antibody application detected increased background fluorescence in all the corneas with more highlighted areas of epithelial defects in abraded infected and uninfected corneas. Confoscan 3 did not show a significant difference between the appearances of HSV-1-infected and control corneas with and without application of the antibody. However, specific staining was confirmed by multiphoton laser confocal microscopy in all infected corneas. Conclusion: Further refinement of currently available ophthalmological tools is required to aid in vivo visualization of herpes simplex keratitis using fluorescein isothiocynate-labeled antibodies.
LanguageEnglish
Pages421-425
JournalCORNEA
Volume28
Issue number4
DOIs
Publication statusPublished - May 2009

Fingerprint

Herpetic Keratitis
Human Herpesvirus 1
Fluorescein
Cornea
Antibodies
Confocal Microscopy
Fluorescence
Simplexvirus
Staining and Labeling

Cite this

Novitskaya, Elena S. ; McGilligan, Victoria ; Moore, Johnny ; Sharma, Anant ; Dean, Simon J. ; Moore, Tara. / Difficulties Imaging Herpes Simplex Keratitis With Fluorescein Isothiocynate-Labeled Anti-HSV-1 Antibodies in an Ex Vivo Model. In: CORNEA. 2009 ; Vol. 28, No. 4. pp. 421-425.
@article{21becdd9a9c0452da068e8155b5c303a,
title = "Difficulties Imaging Herpes Simplex Keratitis With Fluorescein Isothiocynate-Labeled Anti-HSV-1 Antibodies in an Ex Vivo Model",
abstract = "Aim: The aim of this study was to attempt to visualize herpes simplex keratitis in an ex vivo model using currently available ophthalmological equipment and anti-herpes simplex virus I (HSV-1) fluorescein isothiocynate-labeled antibody. Methods: Sixteen donor human corneas were included in this study. Eight corneas were infected with HSV-1, whereas 8 remained uninfected. Abrasions were made on 2 infected and 2 uninfected corneas to assess a possible nonspecific absorption of antibodies in the sites of corneal epithelial defects. Corneas were examined before and after antibody application using a slit lamp, the fluorescein enhancing filter settings of fundus camera, and Confoscan 3. All corneas were further imaged using multiphoton laser confocal microscopy. Results: Before anti-HSV-1 antibody application, no fluorescence was detected in donor corneas with the blue light of the slit lamp and fundus camera at fluorescein enhancing filter settings. Examination with the fundus camera after antibody application detected increased background fluorescence in all the corneas with more highlighted areas of epithelial defects in abraded infected and uninfected corneas. Confoscan 3 did not show a significant difference between the appearances of HSV-1-infected and control corneas with and without application of the antibody. However, specific staining was confirmed by multiphoton laser confocal microscopy in all infected corneas. Conclusion: Further refinement of currently available ophthalmological tools is required to aid in vivo visualization of herpes simplex keratitis using fluorescein isothiocynate-labeled antibodies.",
author = "Novitskaya, {Elena S.} and Victoria McGilligan and Johnny Moore and Anant Sharma and Dean, {Simon J.} and Tara Moore",
year = "2009",
month = "5",
doi = "10.1097/ICO.0b013e31818a7dba",
language = "English",
volume = "28",
pages = "421--425",
journal = "CORNEA",
issn = "0277-3740",
number = "4",

}

Difficulties Imaging Herpes Simplex Keratitis With Fluorescein Isothiocynate-Labeled Anti-HSV-1 Antibodies in an Ex Vivo Model. / Novitskaya, Elena S.; McGilligan, Victoria; Moore, Johnny; Sharma, Anant; Dean, Simon J.; Moore, Tara.

In: CORNEA, Vol. 28, No. 4, 05.2009, p. 421-425.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Difficulties Imaging Herpes Simplex Keratitis With Fluorescein Isothiocynate-Labeled Anti-HSV-1 Antibodies in an Ex Vivo Model

AU - Novitskaya, Elena S.

AU - McGilligan, Victoria

AU - Moore, Johnny

AU - Sharma, Anant

AU - Dean, Simon J.

AU - Moore, Tara

PY - 2009/5

Y1 - 2009/5

N2 - Aim: The aim of this study was to attempt to visualize herpes simplex keratitis in an ex vivo model using currently available ophthalmological equipment and anti-herpes simplex virus I (HSV-1) fluorescein isothiocynate-labeled antibody. Methods: Sixteen donor human corneas were included in this study. Eight corneas were infected with HSV-1, whereas 8 remained uninfected. Abrasions were made on 2 infected and 2 uninfected corneas to assess a possible nonspecific absorption of antibodies in the sites of corneal epithelial defects. Corneas were examined before and after antibody application using a slit lamp, the fluorescein enhancing filter settings of fundus camera, and Confoscan 3. All corneas were further imaged using multiphoton laser confocal microscopy. Results: Before anti-HSV-1 antibody application, no fluorescence was detected in donor corneas with the blue light of the slit lamp and fundus camera at fluorescein enhancing filter settings. Examination with the fundus camera after antibody application detected increased background fluorescence in all the corneas with more highlighted areas of epithelial defects in abraded infected and uninfected corneas. Confoscan 3 did not show a significant difference between the appearances of HSV-1-infected and control corneas with and without application of the antibody. However, specific staining was confirmed by multiphoton laser confocal microscopy in all infected corneas. Conclusion: Further refinement of currently available ophthalmological tools is required to aid in vivo visualization of herpes simplex keratitis using fluorescein isothiocynate-labeled antibodies.

AB - Aim: The aim of this study was to attempt to visualize herpes simplex keratitis in an ex vivo model using currently available ophthalmological equipment and anti-herpes simplex virus I (HSV-1) fluorescein isothiocynate-labeled antibody. Methods: Sixteen donor human corneas were included in this study. Eight corneas were infected with HSV-1, whereas 8 remained uninfected. Abrasions were made on 2 infected and 2 uninfected corneas to assess a possible nonspecific absorption of antibodies in the sites of corneal epithelial defects. Corneas were examined before and after antibody application using a slit lamp, the fluorescein enhancing filter settings of fundus camera, and Confoscan 3. All corneas were further imaged using multiphoton laser confocal microscopy. Results: Before anti-HSV-1 antibody application, no fluorescence was detected in donor corneas with the blue light of the slit lamp and fundus camera at fluorescein enhancing filter settings. Examination with the fundus camera after antibody application detected increased background fluorescence in all the corneas with more highlighted areas of epithelial defects in abraded infected and uninfected corneas. Confoscan 3 did not show a significant difference between the appearances of HSV-1-infected and control corneas with and without application of the antibody. However, specific staining was confirmed by multiphoton laser confocal microscopy in all infected corneas. Conclusion: Further refinement of currently available ophthalmological tools is required to aid in vivo visualization of herpes simplex keratitis using fluorescein isothiocynate-labeled antibodies.

U2 - 10.1097/ICO.0b013e31818a7dba

DO - 10.1097/ICO.0b013e31818a7dba

M3 - Article

VL - 28

SP - 421

EP - 425

JO - CORNEA

T2 - CORNEA

JF - CORNEA

SN - 0277-3740

IS - 4

ER -